Related Experiment Video
Updated: Jun 1, 2026
04:56
Assessment of Social Transmission of Food Preferences Behaviors
Published on: January 25, 2018
Dietary patterns in Alzheimer's disease and cognitive aging
1The Taub Institute for Research in Alzheimer’s Disease and the Aging Brain, Columbia University, New York, NY 10032, USA.
Current Alzheimer Research
|May 25, 2011
Summary
Dietary patterns, not single nutrients, are linked to reduced Alzheimer's disease (AD) risk. Diets rich in fruits, vegetables, and fish, and low in unhealthy fats, support cognitive health in older adults.
Area of Science:
- Nutrition Science
- Neuroscience
- Gerontology
Background:
- Limited research exists on dietary patterns (DPs) and Alzheimer's disease (AD) or elderly cognition, with most studies focusing on single nutrients.
- Dietary patterns offer a more comprehensive approach to understanding diet's complex role in health outcomes.
Purpose of the Study:
- To review different dietary pattern analysis approaches.
- To present existing studies on the association between dietary patterns and the risk of AD or cognitive function in the elderly.
Main Methods:
- Review of studies utilizing three main dietary pattern approaches: hypothesis-based (e.g., Mediterranean diet scores), data-driven (factor/cluster analysis), and reduced rank regression.
- Synthesis of findings from studies assessing the link between identified dietary patterns and cognitive health or AD risk.
Main Results:
- Dietary patterns characterized by high intake of fruits, vegetables, fish, nuts, and legumes, and low intake of meats, high-fat dairy, and sweets are associated with lower odds of cognitive deficits.
- These beneficial dietary patterns appear to reduce the risk of Alzheimer's disease in the elderly population.
Conclusions:
- Dietary pattern analysis is a valuable approach for Alzheimer's disease and aging research due to its comprehensive nature.
- Further research is needed to confirm findings across diverse populations, address methodological challenges, and inform future clinical trials for AD prevention and management.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.